ARTICLE | Company News
Management tracks
June 22, 2016 11:53 PM UTC
Endocyte Inc. (NASDAQ:ECYT) said Ron Ellis resigned as president and CEO. The cancer company promoted CFO and COO Mike Sherman to succeed Ellis. Sherman will remain CFO.
Bristol-Myers Squibb Co. (NYSE:BMY) promoted Murdo Gordon to EVP and chief commercial officer from head of worldwide markets. ...